Cancer immunotherapy turns viral
Year: 2013
Type: editorial
Abstract: The holy grail of anticancer therapy is to selectively eradicate malignant cells while sparing their normal counterparts. Tremendous progresses have been made in this sense during the past decade, ...
Source: OncoImmunology
DOI: 10.4161/onci.24802
Authors: Lorenzo Galluzzi, Enrico Lugli
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,913
OpenAlex ID: W1966259046
